2022
SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020
Gouvea-Reis F, da Silva D, Borja L, de Oliveira Dias P, Percio J, Peterka C, de Oliveira J, Sodré G, Feres C, Dos Santos W, Souza F, Teixeira A, Cilião-Alves D, Romero G, Noronha E, Croda J, Haddad R, Ramalho W, de Moraes C, de Araújo W. SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020. International Journal Of Prisoner Health 2022, 19: 143-156. PMID: 38899623, DOI: 10.1108/ijph-08-2021-0083.Peer-Reviewed Original ResearchSARS-CoV-2 seroprevalenceOverall infection fatality rateInfection fatality rateChemiluminescence enzyme immunoassaySymptomatic individualsOverall SARS-CoV-2 seroprevalenceSARS-CoV-2 antibodiesDiagnostic accuracyAntibody rapid testLateral flow immunochromatographic assayCOVID-19 outbreakAsymptomatic infectionVaccination strategiesEligible individualsHigh seroprevalenceFatality ratePositive casesSeroprevalenceSerological assaysEnzyme immunoassayRapid testPriority groupsMass testingLFIA testRepresentative sample
2012
Tuberculosis control in a highly endemic indigenous community in Brazil
Croda M, Trajber Z, da Costa Lima R, Croda J. Tuberculosis control in a highly endemic indigenous community in Brazil. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 2012, 106: 223-229. PMID: 22365154, DOI: 10.1016/j.trstmh.2012.01.005.Peer-Reviewed Original ResearchConceptsTB treatmentNon-Indigenous populationsTB patientsTB case fatality rateImplementation of DOTSRetrospective cohort studyCase fatality rateNumber of patientsHIV-positive statusTimes higher mortalityHigh rateCohort studyTB controlCase fatalityDOTS implementationHIV prevalenceTuberculosis controlFatality rateHigh mortalityMultivariate analysisPatientsYoung adultsMortalityPriority groupsIndigenous populations